Medical research

How pancreatic cancer defies treatment by leveraging a protein

Pancreatic cancer is the third deadliest cancer in the United States, after lung and colorectal, though far less common. It is also among the hardest to effectively treat, with pancreatic cancer stem cells quickly developing ...

Oncology & Cancer

Drug combo breaks down cancer resistance to immunotherapy

Immunotherapy is a way of treating cancer by reprogramming the patient's immune system to attack their tumor. This cutting-edge approach has significantly impacted the treatment of cancer patients, and already boasts cases ...

Oncology & Cancer

Killing pancreatic cancer with T cells that supercharge themselves

Scientists at UC San Francisco (UCSF) have engineered T cells to produce a potent anti-cancer cytokine, but only when they encounter tumor cells. The immunotherapy eliminated melanoma and pancreatic cancer in mice without ...

Oncology & Cancer

New targets in the fight against pancreatic cancer

Pancreatic cancer remains one of the deadliest malignancies worldwide. Since five-year survival rate for pancreatic ductal adenocarcinoma (PDAC) is only about 3% in patients, PDAC is very difficult to treat with surgery worldwide. ...

Medical research

Preventive therapeutic for diabetes shows promise in mouse study

Researchers from the Liston lab, at the Babraham Institute, have recently published details about a preventative therapeutic for diabetes in mice. The team has been able to prevent diabetes in mice by manipulating signaling ...

Medications

Study shows promise of new anti-KRAS drug for pancreatic cancer

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models ...

page 12 from 40